Application of lipid-lowering drugs in prevention and treatment of NAFLD.
- VernacularTitle:降脂药防治非酒精性脂肪性肝病临床价值
- Author:
Jia SHANG
- Publication Type:Journal Article
- Keywords:
NAFLD;
hyperlipidemia;
lipid-lowering drugs
- From:
Chinese Journal of Practical Internal Medicine
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease(NAFLD)is the Clinicopathological syndrome characterized by diffuse hepatic steatosis from excessive use of alcohol and other specific factors that cause liver damage including simple steatosis,and nonalcoholic steatohepatitis.The pathogenesis of NAFLD is closely related to Insulin resistance and genetic susceptibility.Presently the major treatment of NAFLD is diet control to reduce weight.On the basis of the treatment with dyslipidemia and hypoglycemic drugs or application of weight loss for more than one month,are there still mixed hyperlipidemia or hyperlipidemia with two or more risk factors,need to add Lipid-lowering drugs such as fibrates,statins or Probucol should be considered.The prevention and treatment with lipid-lowering drugs in NAFLD will be summarized in this article.
